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Abstract 
 
This paper describes the development of a comprehensive mathematical model of the human cardiopulmonary 
system that combines the respiratory and cardiovascular systems and their associated autonomous nervous control 
actions.  The model is structured to allow the complex interactions between the two systems and the responses of the 
combined system to be predicted under different physiological conditions. 
The cardiovascular system model contains 13 compartments including the heart chambers operating as a pump and 
the blood vessels represented as distensible tubes configured in a serial and parallel arrangement. The accurate 
representation of the hemodynamics in the system and the good fit to published pressure and flow waveforms gave 
confidence in the modelling approach adopted for the cardiovascular system prior to the incorporation of the 
baroreflex control and the respiratory models. 
An improved baroreceptor reflex model is developed in this research incorporating afferent, central and efferent 
compartments. A sigmoid function is included in the efferent compartment to produce sympathetic and 
parasympathetic nerve outflow to the effector sites. The baroreflex action is modelled using physiological data, its 
interaction with the chemoreflex control is explained and the simulation results presented show the ability of the 
model to predict the static and dynamic hemodynamic responses to environmental disturbances. 
A previously published respiratory model that includes the mechanics of breathing, gas exchange process and the 
regulation of the system is then combined with the cardiovascular model to form the cardiopulmonary model. 
Through comparison with published data, the cardiopulmonary model with the baro-chemoreflex control is validated 
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during hypoxia and hypercapnia. The percentage difference between the predicted and measured changes in the heart 
rates and the mean arterial pressures are within 3% in both cases. The total peripheral resistance correlates well for 
hypoxia but is less good for hypercapnia where the predicted change from normal condition is around 7% compared 
with a measured change of 23%. An example showing the application of the proposed model in sport science is also 
included. 
 
Keywords: Cardiopulmonary systems; Baroreceptor reflex; Chemoreceptor reflex; Mathematical modelling. 
 
NOTATION 
 
A Heart valve area (cm
2
) 
b Bernoulli resistance term (mmHg/ (ml/s)
2
 ) 
e Time varying elastance (mmHg/ml) 
eˆ  Effective time varying elastance with septal coupling (mmHg/ml) 
E Elastance (mmHg/ml)  
f Frequency (Hz) 
G Gain 
HR Heart rate (beats/min) 
k, K Gain or Coefficient 
klr Left-to-right ventricular pressure gain 
krl Right-to-left ventricular pressure gain 
L Inertance (mmHg/ (ml/s
2
) ) 
MAP  Mean arterial pressure (mmHg) 
P Pressure (mmHg) 
PNA Parasympathetic neural firing rate (Hz) 
Q Flow (ml/s) 
R Resistance (mmHg/(ml/s)) 
s Complex variable for Laplace transformation 
SNA Sympathetic neural firing rate (Hz) 
t Time variable (s) 
tac  Time when atrium begins to contract (s) 
tar   Time when atrium begins to relax (s) 
tee  Time of end-ejection at maximum ev (s) 
Tr  Time period of cardiac cycle (s) 
V Volume (ml) 
Φ Volume constant (ml) 
ρ  Density of blood (g/ml) 
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τ Time constant (s) 
τac  Time constant for atrial contraction (s) 
τar  Time constant for atrial relaxation (s) 
τvc  Time constant for ventricular contraction (s) 
τvr  Time constant for ventricular relaxation (s) 
Ω Viscoelastance (mmHg · s/ml) 
 
Subscripts 
a  Atrium 
aa  Aorta 
aff Afferent 
b Blood 
c Central compartment 
it  Intrathoracic 
l  Length for vascular segment 
lv  Left ventricle 
mv Mitral valve 
pc  Pericardium 
r  Radius for vascular segment 
R Arterioles 
s  Interventricular septum  
sˆ  Sympathetic nerve activity 
rv  Right ventricle 
v  Ventricle 
vˆ  Vagal (parasympathetic) nerve activity 
V Veins 
vlv  Heart valves 
 
 
1. INTRODUCTION 
During the past five decades, the application of mathematical modelling to the cardiovascular and respiratory 
systems has received considerable interest with the aim that such an approach could assist in understanding the 
function and effects of the diseases associated with these two systems. With this purpose in mind, the models that 
have been developed to date tend to be limited to a particular function or disease. For example, some researchers 
have developed very complicated cardiovascular models without fully considering the effect of the respiratory 
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system [1-7] while others have concentrated on the development of the respiratory model but have ignored the 
important contribution of the cardiovascular system [8-11]. Since the 1980's, there has been a move to producing 
comprehensive cardiopulmonary models that allow the interaction between these two systems to be investigated [12-
16]. This significantly broadens the application of the cardiopulmonary model.  
The objective of the research reported here is to develop a comprehensive human cardiopulmonary model, including 
detailed representations of the respiratory and cardiovascular systems, which is capable of predicting the complex 
interactions between the two systems and their responses under different physiological conditions. A cardiovascular 
model including baroreflex is developed. This model is combined with a respiratory model that includes the gas 
exchange process and the antagonistic interaction of the baroreflex and the chemoreflex. The model is validated 
using published data and an example of the application of the model in the context of physical exercise is provided. 
 
2. MODELLING THE CARDIOVASCULAR HYDRAULIC SYSTEM 
In engineering terms, the cardiovascular system consists of a dual pump (heart), a series of distributing and collecting 
tubes (arteries and veins), and an extensive system of thin vessels that permit rapid gas exchange between the tissues 
and the vascular channels (capillaries). The heart consists of two pumps in series: one to pump blood through the 
lungs for exchange of oxygen (O2) and carbon dioxide (CO2) (the pulmonary circuit) and the other to circulate blood 
to all other tissues of the body (the systemic circuit). Unidirectional flow through the heart is achieved by the 
appropriate arrangement of effective flap valves.  
The proposed model consists of 13 compartments including the pulmonary capillaries, the pulmonary arteries and 
veins, the left and right heart, the aorta, the systemic arteries and veins, the vena cava, the systemic capillaries, the 
intrathoracic compartment, the pericardium and the interventricular septum. 
Nonlinearity aspects associated with the arteries are incorporated into the model to produce realistic arterial pressure 
and volume waveforms. However, the discontinuity of vein compliance due to venous collapse is not currently taken 
into account. The intrathoracic pressure is included as it is important to represent the interaction of the respiratory 
and cardiovascular systems. The characterisation of the individual compartments of the model are described in the 
following subsections. 
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2.1. Heart chambers  
The heart is represented by a four-chamber model associated with the right and left ventricles and atria. Each 
chamber is modelled as a time-varying elastance model as proposed by Suga [17]. The elastance term e is assumed to 
vary over the cardiac cycle according to an exponential charge-discharge waveform and is characterised by a time 
constant τ , a baseline elastance bE  and an amplitude elastance term aE  [5].  
The pressure-volume equations for the ventricles are given by 
 vvv VeP =  (1) 
 with 
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 where 
eet
ve  refers to the elastance at time eet  
 vaE  and vbE are the ventricle elastance amplitude and baseline values, respectively. 
The equations for the atria are represented in a similar form 
 aaa VeP =  (3) 
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 where aaE  and abE are the atria elastance amplitude and baseline values, respectively. 
The time period of the cardiac cycle is HR/Tr 60=  where HR  is the heart rate in beats per minute and the cardiac 
timing events specified by the values eet , act  and art  are described by linear approximations obtained by Beneken 
and De Wit [18]. These timing values are fed into the heart model to generate the cardiac activation functions.  
 
2.2.  Heart valves 
The dynamics of the heart valves are described by Bernoulli’s equation, which offers the possibility of investigating 
the acceleration/deceleration of the flow and the effect of valve stenosis [19]. This implies that the pressure drop 
caused by flow separation at the exit of the valve is proportional to the square of flow. An inertial term accounts for 
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the acceleration and deceleration of flow and viscous resistance is also included. The pressure-flow relation for a 
particular valve is given by 
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where )13332( 2vlvv A/b ×= ρ  with the constant term 1333 being a conversion factor when using pressure in mmHg. 
2.3. Interaction between left and right heart 
 
Interactions between the left and right heart include: (i) pressure coupling through the interventricular septum, (ii) 
volume coupling among the chambers in the pericardium, and (iii) hemodynamic coupling via the pulmonary 
circulation. The shift of the septum is represented by an elastic compartment using the approach described by 
Maughan et al. [20]. Under this assumption, the left ventricular pressure is the sum of the effective left ventricle 
elastance times the left ventricle volume and the “cross-talk” pressure from the right ventricle and is given by 
 rvrllvlvlv PkVeˆP +=  (6) 
where the right-to-left ventricular pressure )( lvslvrl eE/ek += and the effective elastance with septum coupling is 
rlslv kEeˆ = . 
Similarly, the right ventricle pressure is given by  
 
lvlrrvrvrv pkVeˆP +=                             (7) 
 where )eE/(ek rvsrvlr +=  and lrsrv kEeˆ =   
In addition to the pressure coupling between the ventricles, the volume coupling is included in all chambers in the 
pericardium. In the model proposed by Sun et al. [5], this is represented by a pericardial compartment with an 
exponential pressure-volume relationship given by 
 pcpcpc
/)VV(
pcpc eKP
Φ0−=   (8) 
pcΦ  is the volume constant while Vpc0  is the volume offset and Kpc is set to unity according to Sun’s model. Vpc is 
the sum of heart and pericardial fluid volumes and is set to be 30 ml under normal conditions.  
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2.4. Arteries, veins and capillaries 
 
Arteries are represented by capacitance, resistance and inertance terms. Viscoelastance is also included though it has 
less effect on the flow dynamics than the other three terms. Nonlinearity is introduced to the capacitance using an 
exponential pressure-volume relationship. For the aorta, the pressure-volume relationship is given by [5] 
 aa
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sa
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aaaaaasaaa
aa L/
dt
dV
dt
dV
QR)PP(
dt
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 aaaaaa EP Φ=                                          (10) 
              aaaa
/V
aa eEE
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Although the physiological characteristics of the veins are different from those of the arteries, Equations (9) - (11) 
can be used to describe the veins with some adjustment. A higher value is assigned to the volume constant Φ  as the 
capacitance is relatively constant and veins are more compliant than arteries.  
Nutrients and waste products exchange between blood and tissue in the capillaries, and for this reason, the capillaries 
must be included to form an overall circulatory model. The pulmonary capillaries share the same mathematical 
model as arteries and veins.  This approach was used by Sun et al. [5] where good agreement with clinical data was 
obtained. From a physiological point of view, the systemic capillaries have a huge cross-sectional area which slows 
down the blood flow so that chemical metabolic energy exchange can take place. The resistance of the systemic 
capillaries is determined by the resistance of the arterioles supplying the systemic capillaries and by the number of 
open precapillary sphincters. As a result, the resistance is expected to play a dominant role, rather than capacitance 
and inertance in the systemic capillary model. 
3. CARDIOPULMONARY MODEL INTEGRATION FOR SIMULATION AND CONTROL 
A respiratory model, based on the model developed by Tomlinson et al. [11] was combined with the proposed 
cardiovascular model to form a detailed model of the cardiopulmonary system. The respiratory model of Tomlinson 
et al. [11] was used in the context of interaction with underwater breathing equipment and further improved through 
the incorporation of the mechanical and chemical control of breathing [21, 22]. 
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The coupling between the respiratory and the cardiovascular systems includes the gas exchange process, the effect of 
breathing on the cardiovascular system and the blood gas contents on the hemodynamics.  In the integrated 
cardiopulmonary model represented by the block diagram in Figure 1, the gas constituents (oxygen, carbon dioxide 
and nitrogen) pass through the nose and mouth to the tracheo-bronchial tree and reach the lung model where the gas 
exchange with the circulatory system takes place. The brain model detects the lung volume change and sends the 
required variation in thoracic force with respect to time to the pleural compartment. The pleural compartment model 
then calculates the pleural pressure acting on the lung to stimulate breathing. The gases quantified in terms of the 
constituents concentrations are carried by the blood from the lung to other cardiovascular compartments. The left and 
right heart models, which have pressure and volume coupling between the two chambers through the pericardium, 
pump the blood through the whole body.  
4. DEVELOPMENT OF A CARDIOPULMONARY BARO-CHEMORECEPTOR CONTROL MODEL 
For the regulation of the cardiopulmonary system, the schematic representation of the interaction between the 
chemoreflex and the baroreflex is shown in Figure 2. The peripheral chemoreceptor detects the change of the oxygen 
and carbon dioxide partial pressures (PO2 and PCO2) in the brain artery and determines the operating point for the 
baroreceptor model. The central chemoreceptor is sensitive to the brain arterial PCO2 and when it is stimulated, the 
gain of the sympathetic outflow is increased accordingly. The parasympathetic outflow and sympathetic outflow are 
sent to the effector sites which control the hemodynamic parameters including heart rate, cardiac contractility, 
venous unstressed volume and peripheral resistance. 
The most important short-term regulation of the arterial pressure and cardiovascular function is performed by the 
baroreceptor reflex control system. The proposed model is represented as a three-compartment system: afferent, 
central and efferent compartments as shown in Figure 2. The input parameter to the arterial baroreceptor is the mean 
aortic pressure (MAP). The peripheral chemoreceptor detects the change of the oxygen and carbon dioxide partial 
pressures (PO2 and PCO2) in the brain artery and sets the operating point for the baroreceptor model. The activity of 
sympathetic and parasympathetic nerves are passed to the effector sites including the heart, veins and arterioles. The 
central chemoreceptor is sensitive to the brain arterial carbon dioxide partial pressures and when it is stimulated the 
gain of the sympathetic outflow is increased accordingly. The four main parameters involved in the regulation are the 
heart rate, the cardiac contractility, the venous compliance and the peripheral resistance. These parameters are fed 
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into the hydraulic cardiovascular model and the resulting aortic pressure is fed back to the controller (the 
autonomous nervous system). The structure of the mathematical models for each compartment is described in the 
following sections using the Laplace transform for convenience as these will be represented later in block diagrams.  
4.1. Afferent compartment  
 
The mean arterial pressure (MAP) is used as the input to the afferent compartment. Carotid pressure is not used 
because this pressure is the same as the arterial pressure in the supine position. Since the mean aortic pressure is used 
as the input, the baroreceptor response to the change of pressure can be ignored. However, features such as pressure 
threshold and time delay are still included in the model. 
The baroreceptor action potential frequency has a linear relationship with the mean arterial pressure within a pressure 
threshold [23]. At a particular steady pressure, there is a certain rate of discharge by the neurons in the baroreceptors. 
This rate increases when the arterial pressure rises and decreases when the pressure falls. A first order filter is used to 
represent the delay response to the pressure change and a gain element is used to represent the rate of discharge: 
 
s
MAP
GP
aff
affaff τ+
=
1
  (12) 
 
4.2. Central compartment 
The primary integrating centre for the baroreceptor reflexes is a diffuse network of highly interconnected neurons 
called the medullary cardiovascular centre, located in the brainstem medulla oblongata. The central compartment 
compares the mean arterial pressure and the arterial pressure demand, and gives out the difference between the 
demanding and actual arterial pressures: 
 
s
P
PP
c
demand
afferror τ+
−=
1
 (13)  
The demand pressure Pdemand is the arterial pressure at the baroreflex operating point and again a first order filter is 
used to represent the delay through the central compartment. 
 
4.3. Efferent compartment 
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The efferent compartment comprises parasympathetic (PNA) and sympathetic (SNA) divisions which exhibit a 
sigmoid shape between the pressure and the nerve activities [24]. The two sigmoid functions in the two divisions of 
the efferent nerve outflow are given by: 
 )1(
1
SNAk/P
k/P
minmax G
e
eSNASNA
SNA
sˆerror
sˆerror
∆+
+
+
=         (14) 
where 
 )4()( sˆminmaxsˆ S*/SNASNAk −=     (15) 
 
 
vˆerror
vˆerror
k/P
k/P
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e
ePNAPNA
PNA
+
+
=
1
     (16) 
where 
 )4()( vˆminmaxvˆ S*/PNAPNAk −=     (17)  
sˆS  and vˆS  are the slopes at the operating point of the sigmoid function. 
4.4. Control of heart rate 
 
Warner and Russell [25] investigated the effects of sympathetic and parasympathetic stimulation and the combined 
effect on the heart rate by stimulating these nerves to a particular frequency level. Three features were drawn from 
the experiments: 
(i) the heart rate rises faster than it falls back to the control level; 
(ii) the change in the heart rate due to sudden nerve stimulation is dependent on the frequency stimulated 
(this is more noticeable for sympathetic than parasympathetic nerve activity); 
(iii) the gain of the response is nonlinear. 
Based on the above experimental observations, an overall block diagram for the control scheme for the heart rate is 
proposed in Figure 3. A variable time constant first order transfer function is included in the path of both nerve 
divisions at the effector sites to represent the different heart rate response to increment and decrement of the nerve 
frequency. An exponential relationship with the input nerve frequency is used for the sympathetic branch time 
constant. A second order polynomial function is used to represent the nonlinear steady state gain as proposed by 
Levy and Zieske [26]. However, the steady state gain is only valid when the stimulated frequency is less than 8 Hz. 
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According to experimental data obtained by Warner and Russell [25] and by Levy and Zieske [26], an exponential 
function limits the gain and time delays for both nerve divisions. Therefore, a pure time delay is included in both 
divisions.  
The interactions between the two nerve divisions on the control of the heart rate are very complicated. Methods 
proposed by Warner and Russell [25] and Levy and Zieske [26], have been simplified, and combined to provide a 
more comprehensive form as follows: 
 
 HRHRHR ∆+= 0  (18) 
 
 vˆsˆvˆsˆ HRHRcHRHRHR ∆∆∆∆∆ ⋅⋅++=  (19) 
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4.5. Other effector sites 
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Other effector sites including arterioles and veins share similar characteristics. Sympathetic nerve outflow sends a 
signal to the effector sites which include a static gain, a first order filter and a pure time delay as shown in equation 
(29).  The first order filter and the pure time delay represent the main aspects of the response time pattern. It is worth 
noting that the gain for venous compliance is negative while the others are positive.  
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4.6. Chemical control of cardiovascular system 
 
The relationship between the mean arterial pressures and the gas content in the blood is given by Rothe et al [27]:  
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where 
1k , 2k  and 3k  are set coefficients, and 2O,bP  and 2CO,bP  are the oxygen and carbon dioxide partial pressure in 
the blood, respectively. 
The mean arterial pressure ∆MAP is the arterial pressure at the baroreflex operating point in the central compartment 
of the baroreflex model described above. Thus the resetting of the baroreflex is linked to the peripheral 
chemoreceptor. 
The relationship between the percentage change of the sympathetic nerve activity gain and the PCO2 is based on an 
experiment undertaken by Lioy and Trzebski [28] where the action of the baroreceptors,
 
peripheral chemoreceptors, 
and lung-stretch receptors was excluded:  
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4.7. Regulation of cerebral blood flow 
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Local regulation of the cerebral circulation is predominant over other neural factors because, among the various body 
tissues, the brain is the least tolerant to ischemia (insufficient blood flow). Generally, the total cerebral blood flow is 
constant and shows excellent auto-regulation between about 60 and 160 mmHg mean arterial pressure [29]. The 
cerebral vessels are known to be sensitive to PCO2 and brain O2 supply.  In addition, the flow is also influenced by 
metabolic factors and the following equations were used to calculate the responses of the cerebral blood flow adapted 
from Patterson et al [30]: 
 
 Qbbco,bo,bmetabolic,bb /QQQQQ τ∆∆ )( 22 −++=
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5. SIMULATION RESULTS AND MODEL VALIDATION  
In this section, the simulation of the complete cardiopulmonary system incorporating the reflex control, developed in 
the previous sections, is presented.  The model validation is based on typical physiological data for healthy subjects 
published in the literature. First, the cardiovascular model developed in section 2 is validated and a sensitivity test is 
performed in order to identify the parameters that have a high impact on the predicted response. The proposed 
cardiovascular system is then combined with an existing respiratory model [11, 22] to form a cardiopulmonary 
system which is controlled by the proposed baro-chemoreceptor reflex model for validation of the complete system. 
The model was numerically implemented using the Bathfp dynamic simulation package developed at the University 
of Bath, which had been previously used to develop physiological models [21]. This software is based on a modular 
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modelling approach and uses a variable order and variable time-step numerical integration algorithm to solve the 
resulting algebraic and differential equations with respect to time. 
5.1. Validation of the cardiovascular hydraulic model 
Parameters were firstly estimated in terms of the physiological range or the order of magnitude for the parameter 
value. The vascular resistances and inertances were calculated on the basis of fluid dynamic laws and the dimensions 
of the anatomic compartments that the individual sections of the model represent [31]. The heart valve parameters 
(inertance, resistance, and Bernoulli term for each valve) were obtained from a study by Sun et al. [32] using 
Doppler echocardiography data. The values for the parameters that could not be found from literature were fine 
tuned within their physiological ranges by trial and error by inspection of the predicted pressure and flow waveforms. 
A major determinant of the circulatory dynamics is the vascular elastance, which is nonlinear and specified by two 
parameters (E0 and Φ). For each elastance, these two parameters were iteratively adjusted until an acceptable 
representation for the hemodynamic waveforms and the average volume stored in the elastance was achieved. The 
volume constant Φ is generally of the same order of magnitude as the volume in the elastance. The baseline elastance 
for the contracting chambers were also determined on the basis of volume distribution in the heart. 
 
Two criteria were used to justify the results: the representation of the baseline hemodynamics in various parts of the 
system and the fit to published pressure and flow waveforms.  
To aid tuning the parameters, a sensitivity analysis was performed on the model based on a gain factor that defines 
the sensitivity of the model [5] 
 
parameter (model) affected of change %
index ic)(hemodynam affected ofchange %
  Gainy Sensitivit =  (35) 
The chosen hemodynamic indexes were data routinely measured to assess the physiological state of the 
cardiovascular system such as cardiac output, systolic/diastolic aortic pressures, end-diastolic right and left 
ventricular pressures, pulmonary arterial pressure, right and left ventricular volumes, mean right and left atria 
pressures, total pulmonary volume, total cardiac volume and systemic venous blood volumes [5]. 
The results of the sensitivity analysis showed that the simulated hemodynamics was insensitive to most individual 
model parameters such as inertance, capacitance, resistance and viscoelastance except for peripheral capillaries 
resistance. The systemic and pulmonary veins which account for the preload capacitances for the right heart and left 
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heart were sensitive and are a major determinant of cardiac output and aortic pressure.  The pericardial volume offset 
was found to be the most sensitive parameter due to the constraint effect of the pericardium being dominant. 
Figure 4 compares the predicted pressure waveforms obtained using the parameter values presented in Table A1 with 
the experimental traces obtained by Sugawara et al. [33]. Although Sugawara’s results were derived from canine in-
vivo data, pressure waveforms obtained for both human and dogs show similar responses. The main physiological 
characteristic difference between the hearts of dogs and humans is the diameter of the coronary sinus which is not 
included in the model [34]. 
The predicted heart valve flow rate shown in Figure 5 decreases to zero abruptly due to the closure mechanism which 
assumes that the valve flow ceases when the pressure gradient becomes zero. As the aortic valve closes and the aortic 
walls relax, a rebound pressure wave against the aortic valve occurs, known as the dicrotic notch. The shorter aortic 
valve opening period due to this closure mechanism results in a relatively less distinctive dicrotic notch in the aortic 
pressure as shown on the expanded time scale of the pressure waveform in Figure 4 at around 1.95 seconds. 
Backflow and noise during the pressure decreasing phase for the aortic and mitral valves are neglected since this 
level of detail is beyond the scope of the current work. 
 
5.2. Validation of the cardiopulmonary baro-chemoreceptor control model 
 
The validated cardiovascular system was then combined with an existing respiratory model [21] whose parameters 
given in Table A3 are obtained from Lo [22] for the respiratory model, from Rothe et al [27] for the peripheral 
chemoreceptor and from Lioy and Trzebski [28] for the central chemoreceptor. The values of the parameters that 
define the baroreflex control mechanism are shown in Table A2. All the parameters have been assigned on the basis 
of clinical or physiological literature. Specifically, the time delay and the time constant for the first order filter are 
reported in [6] and the parameters regarding efferent compartment and heart rate control are based on the 
experimental data presented in [24].  
The cardiopulmonary model was initially assessed without cerebral autonomic control to predict the response for a 
human at rest when quiet breathing in the supine position, with a heart rate of 70 beats per minute and a respiratory 
frequency of 12 breaths per minute. Simulations at these conditions gave results similar to typical values of partial O2 
and CO2 pressures in various vessels of the circulatory system as published by Berne and Levy [24]. 
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The proposed autonomic control model and the interactions between baroreceptors and chemoreceptors were 
assessed during hypoxia (gas mixture 12% O2 and 88% N2) and hypercapnia (gas mixture 5% CO2 and 95% O2).  
First, the hypoxic gas mixture was used to stimulate the peripheral chemoreceptor. The changes in the alveolar 
partial pressure of CO2 and O2 following the step input of the inspired gas mixture introduced at 100 seconds are 
shown in Figure 6. As expected, during the denervation of the baroreceptor, the parasympathetic nerve outflow 
decreases and the sympathetic nerve outflow increases resulting in the increased heart rate, as shown in Figure 7, due 
to the predominance of the cardiac sympathetic over the cardiac vagal activation. However, when the baroreceptor 
and the chemoreceptor are both innervated, the activation of the chemoreceptors inhibits the baroreflex which leads 
to an increase in the blood pressure (Figure 8). The activation of the baroreflex caused by the increased blood 
pressure blunts the change of the sympathetic and parasympathetic outflows leading to smaller changes of the two 
autonomic division outflows and a smaller increase in the heart rate (Figure 9) compared to the case of a denervated 
baroreceptor. The total peripheral resistance only experiences very small changes as shown in Figure 10.   
A quantitative comparison between the simulated results (steady-state percentage change in heart rate, mean arterial 
pressure and total peripheral resistance) obtained from the proposed model and the experimental results reported by 
Cooper et al [35] in humans’ during hypoxia is shown in Figure 11. The agreement between the model and the 
experimental results is considered to be good (less than 1% difference) although the changes obtained from the 
model are slightly higher than those obtained from experiment. Therefore, the model is considered to be capable of 
simulating the resetting of the baroreflex by activating the chemoreceptor and the dynamic interaction of the 
baroreceptor and chemoreceptor reflexes. 
In a similar manner, the effects of hypercapnia were simulated by applying an inspired gas mixture of 5% CO2 and 
95% O2. To highlight the interaction between the central chemoreceptor and the other receptors of the autoregulatory 
model, Figures 12 and 13 present a quantitative comparison of simulation results and published experimental data 
with and without the activation of the central chemoreceptor. It is clear that without the central chemoreceptor, the 
model produces very different results to the experiment and the signs of the predicted changes are in the opposite 
direction to the measured data (Figure 12). However, when the central chemoreceptor is included, the model 
produces much more satisfactory results with the predicted heart rate and mean arterial pressure changes being 
within 3% of the measured values (Figure 13). For the total peripheral resistance, the predicted change from normal 
condition is around 7% compared with a measured change of 23% although it should be noted that the measurements 
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were subject to a ±20% variation. The results produced here justify the assumption that the central chemoreceptor 
has an effect on the gain of the sympathetic nerve activity.  
 
6. CARDIOPULMONARY MODEL APPLICATIONS 
The model developed in this paper for the cardiopulmonary system can be used for clinical, physiological or training 
applications. The modularity and the flexibility of the model are such that basic compartment and parameter models 
can be changed or adjusted to predict cardiac and respiratory responses under different physiological conditions such 
as healthy subjects during exercise or patients with lung or cardiac diseases. One example is given below for 
illustration in the context of sport science. 
The cardiovascular and respiratory adjustments in exercise consist of a combination and integration of neural and 
local (chemical) factors [29]. The cardiopulmonary model developed here will be used to predict the cardiovascular 
and respiratory responses during exercise using typical measured traces from one experiment presented in Figure 14 
obtained before and during exercise by Toska and Eriksen [36].   
The baroreflex is generally considered not to be an important controller of the circulation during exercise because 
chronic denervation of the baroreceptors does not cause an obvious deficit in blood pressure stability or level once 
the responses to moderate-to-heavy exercise have stabilized [37]. However, referring to Figure 14, a sudden transient 
drop in blood pressure is apparent at the onset of exercise after baroreceptor denervation indicating that the 
baroreceptor reflex remained sensitive at the onset of exercise.  This result is supported by Melcher et al. [38] who 
also presented clear evidence of maintained baroreflex sensitivity during exercise.  
The effect of the baroreflex on the cardiovascular system at the onset of exercise can be simulated by shifting the 
operating point of the central compartment and locally inducing vasodilatation in the exercising muscles. Toska and 
Eriksen [36] recorded the responses of 10 healthy men at the onset of moderate, dynamic exercise while supine. The 
data used here for parameterisation is the average of the 10 responses.  The shift of the operating point was estimated 
to be 7% by Elstad et al [39]. It should be noted that this shift is directly proportional to the intensity of exercise [40].  
The vasodilatation can be modelled by decreasing the peripheral resistance with a time constant of 5.5 seconds [39]. 
An appropriate value for the resistance is estimated to be 0.18 mmHg· s/ml according to Toska and Eriksen’s 
experiment [36].   
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The predicted cardiovascular responses at the onset of exercise at time 50s (indicated by the vertical dotted line) 
included in Figure 15 show the same trend as the experimental results shown in Figure 14. For example, after the 
onset of exercise, both the experimental and simulated heart rates increase by about 10 beats per minute. A transient 
decrease in stroke volume (indicated by the arrow on Figure 15) at the onset of exercise delays the increase in 
simulated cardiac output by a few seconds. The stroke volume then returns close to its resting level and the cardiac 
output increases in parallel with heart rate. Mean arterial pressure shows a transient decrease during the first few 
seconds of exercise before increasing to a level slightly above the resting value. The total peripheral conductance 
(reciprocal of total peripheral resistance) also increases to a higher level and then remains reasonably constant for the 
rest of the exercise period.  
 
7. CONCLUSIONS 
This paper describes the development of a comprehensive mathematical model of the human cardiopulmonary 
system that combines the respiratory and cardiovascular aspects and their associated control actions. The 
cardiovascular system model contains 13 compartments, including the heart chambers and the blood vessels, to 
represent the important features of the blood circulation. The parameters of the model are obtained from published 
clinical and physiological data and a sensitivity analysis is undertaken to provide guidance on the tuning of the 
model to achieve realistic blood pressure and flow waveforms to show  good correlation with published experimental 
results. The validated cardiovascular model is then combined with an existing respiratory model, where the 
interactions between both systems are represented and a baro-chemoreceptor reflex control system is developed. The 
simulations of the complete control cardiopulmonary system show that the proposed model is capable of predicting 
the complex interactions between the cardiovascular system and the respiratory system. This has also been validated 
during hypoxia and hypercapnia through comparison with published data. The control algorithm explains the 
regulation of the cardiopulmonary system and allows further neuro-hormonal regulation mechanism to be easily 
integrated in the future.  
The proposed model can be a useful tool in clinical demonstration and education as well as supporting research in 
areas including sport sciences. The response of the cardiopulmonary system during physical exercise is an example 
included in this paper for illustration. A future application envisaged for this research is an extension of the work of 
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Tomlinson et al [11] on the computer simulation of the human interaction with underwater breathing equipment with 
a more integrated and complete cardiopulmonary model.     
 
REFERENCES 
1  Boyers, D. G., Luetsche, J. A., and Cuthbert, J. G.  Simulation of Human Cardiovascular System - Model with 
Normal Responses to Change of Posture, Blood Loss, Transfusion, and Autonomic Blockade. Simulation, 1972, 
18(6), 197-206. 
2  Hyndman, B. W. A digital simulation of the human cardiovascular system. Infor. J., 1972, 10, 8-35. 
3  Leaning, M. S., Pullen, H. E., Carson, E. R., and Finkelstein, L.  Modelling a complex biological system:  the 
human cardiovascular system. 2. Model validation reduction and development. Transactions on Instrumentation, 
Measurement and Control, 1983, 5, 87-98. 
4 Sud, V. K., Srivasan, R. S., Charles, J. B., and Bungo, M. W. Mathematical modelling of the human 
cardiovascular system in the presence of stenosis. Phys. Med. Biol.,1993, 38(3), 369-378. 
5 Sun, Y., Beshara, M., Lucariello, R. J., and Chiaramida, S. A.  A comprehensive model for right-left heart 
interaction under the influence of pericardium and baroreflex. Am. J. Physiol, 1997, 272(3 Pt 2), H1499-H1515. 
6 Ursino, M. and Magosso, E.  Role of short-term cardiovascular regulation in heart period variability: a modeling 
study. American Journal of Physiology-Heart and Circulatory Physiology, 2003, 284(4), H1479-H1493 
7 Kim, H. J., Jansen, K. E. and Taylor, C. A. Incorporating autoregulatory mechanisms of the cardiovascular 
system in three-dimensional finite element models of arterial blood flow. Annals of Biomedical Engineering, 
2010, 38 (7), 2314–2330 
8 Zacek, M. and Krause, E. Numerical simulation of the blood flow in the human cardiovascular system. J 
Biomech., 1996, 29(1), 13-20 
9  Grodins, F. S., Buell, J., and Bart, A. J. Mathematical analysis and digital simulation of the respiratory control 
system. J. Appl. Physiol., 1967, 22(2), 260-276. 
10 Liu, C. H., Niranjan, S. C., Clark, J. W., Jr., San, K. Y., Zwischenberger, J. B., and Bidani, A. Airway 
mechanics, gas exchange, and blood flow in a nonlinear model of the normal human lung. J. Appl. Physiol., 1998, 
84(4), 1447-1469. 
11 Tomlinson, S. P., Lo, J. K. W., and Tilley, D. G. Computer simulation of human interaction with underwater 
breathing equipment. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in 
Medicine, 1994, 208(4), 249-261. 
12 Ben-Tal, A. Simplified models for gas exchange in the human lungs. Journal of Theoretical Biology, 2006, 
238(2), 474-495. 
  20 
13  Lu, K., Clark, J. W., Jr., Ghorbel, F. H., Ware, D. L., and Bidani, A. A human cardiopulmonary system 
model applied to the analysis of the Valsalva maneuver. Am. J. Physiol Heart Circ. Physiol , 2001, 281(6), 
H2661-H2679. 
14  Ursino, M., Magosso, E., and Avanzolini, G. An integrated model of the human ventilatory control system: the 
response to hypercapnia. Clinical Physiology , 2001, 21(4), 447-464. 
15  Ursino, M., Magosso, E., and Avanzolini, G. An integrated model of the human ventilatory control system: the 
response to hypoxia. Clinical Physiology, 2001, 21(4), 465-477. 
16 Lin, J. Mathematical modelling of the human cardiopulmonary system, PhD Thesis University of Bath, 2007. 
17 Suga, H. Theoretical Analysis of A Left-Ventricular Pumping Model Based on Systolic Time-Varying 
Pressure/Volume Ratio. IEEE Transactions on Biomedical Engineering, 1971, BM18(1), 47-54. 
18 Beneken, J. and Dewit, B. A physical approach to hemodynamic aspects of the human cardiovascular system. In 
Physical Bases of Circulatory Transpport: Regulation and Exchange (Eds E. Reeve & A. Guyton), 1967, 1-45.  
19 Fung, Y. C. Biodynamics: Circulation. Springer-Verlag, New York, 1984. 
20  Maughan, W. L., Sunagawa, K., and Sagawa, K. Ventricular systolic interdependence: volume elastance model 
in isolated canine hearts. AJP - Legacy , 1987, 253(6 Pt 2), H1381-H1390. 
21 Tomlinson, S. P., Tilley, D. G., and Burrows, C. R. Computer-Simulation of the Human Breathing Process. 
IEEE Engineering in Medicine and Biology Magazine, 1994, 13(1), 115-124. 
22 Lo, J. K. W.,  Mathematical modelling of mixed gas breathing equipment and associated systems. PhD, 
University of Bath, 1995 
23 Itani, T. F. and Koushanpour, E. A mathematical model of the arterial baroreceptors. Proceeedings of the 
Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1989, 289-299. 
24  Kollai, M. and Koizumi, K. Cardiac Vagal and Sympathetic-Nerve Responses to Baroreceptor Stimulation in the 
Dog. Pflugers Archiv-European Journal of Physiology, 1989, 413(4), 365-371. 
25 Warner, H. R. and Russell, R. I. C. H.  Effect of Combined Sympathetic and Vagal Stimulation on Heart Rate 
in the Dog. Circulation Research, 1969, 24(4), 567-573. 
26 Levy, M. N. and Zieske, H. Autonomic control of cardiac pacemaker activity and atrioventricular transmission. 
Journal of Applied Physiology, 1969, 27(4), 465-470. 
27  Rothe, C. F., Maass-Moreno, R., and Flanagan, A. D. Effects of hypercapnia and hypoxia on the 
cardiovascular system: vascular capacitance and aortic chemoreceptors. Am. J. Physiol, 1990, 259(3 Pt 2), H932-
H939. 
28  Lioy, F. and Trzebski, A. Pressure effect of CO2 in the rat: different thresholds of the central cardiovascular and 
respiratory responses to CO2. J. Auton. Nerv. Syst., 1984, 10(1), 43-54. 
  21 
29 Berne, R. M. and Levy, M. N.  Physiology. 1988 (The C.V.Mosby Company, USA). 
30 Patterson, J. L., Jr., Goetz, R. H., Doyle, J. T., Warren, J. V., Gauer, O. H., Detweiler, D. K., Said, S. I., 
Hoernicke, H., McGregor, M., Keen, E. N., Smith, M. H., Jr., Hardie, E. L., Reynolds, M., Flatt, W. P., and 
Waldo, D. R. Cardiorespiratory dynamics in the ox and giraffe, with comparative observations on man and other 
mammals. Ann. N. Y. Acad. Sci., 1965, 127(1), 393-413. 
31 Sun, Y.  Modeling the dynamic interaction between left ventricle and intra-aortic balloon pump. AJP – Legacy, 
1991, 261(4 Pt 2), H1300-H1311. 
32 Sun, Y., Sjoberg, B. J., Ask, P., Loyd, D., and Wranne, B. Mathematical model that characterises transmitral 
and pulmonary venous flow velocity patterns. AJP – Legacy, 1995, 268(1 Pt 2), H476-H489. 
33 Sugawara, M., Kajiya, R. D., Kitabatake, A., and Matasuo, H. Blood Flow in the heart and Large Vessels. 
1989 (Springer-Verlag, Tokyo). 
34 Iiazzo, P. A., Handbook of Cardiac Anatomy, Physiology, and Devices. 2005 (Humana Press, Totowa, New-
Jersey). 
35 Cooper, V. L., Pearson, S. B., Bowker, C. M., Elliott, M. W., and Hainsworth, R. Interaction of 
chemoreceptor and baroreceptor reflexes by hypoxia and hypercapnia - a mechanism for promoting hypertension 
in obstructive sleep apnoea. The Journal of Physiology, 2005, 568(2), 677-687. 
36 Toska, K. and Eriksen, M. Peripheral Vasoconstriction Shortly After Onset of Moderate Exercise in Humans. 
Journal of Applied Physiology, 1994, 77(3), 1519-1525. 
37 Rowell, L. B., O’Leary, and D. S. Reflex Control of the Circulation During Exercise - Chemoreflexes and 
Mechanoreflexes. Journal of Applied Physiology, 1990, 69(2), 407-418. 
38  Melcher, A. and Donald, D. E. Maintained ability of carotid baroreflex to regulate arterial pressure during 
exercise. AJP - Heart and Circulatory Physiology, 1981, 241(6), H838-H849. 
39  Elstad, M., Toska, K., and Walloe, L. Model simulations of cardiovascular changes at the onset of moderate 
exercise in humans. Journal of Physiology-London, 2002, 543(2), 719-728. 
40  Walgenbach, S. C. and Donald, D. E. Inhibition by Carotid Baroreflex of Exercise-Induced Increases in 
Arterial-Pressure. Circulation Research, 1983, 52(3), 253-262. 
 
 
 
  22 
APPENDIX A – Cardiopulmonary system parameters 
Table A1 – Cardiovascular parameters 
  
Pulmonary 
arteries 
Pulmonary 
capillaries 
Pulmonary 
veins Aorta 
Systemic 
arteries 
Systemic 
capillaries 
Systemic 
veins 
Vena 
cava 
R (mmHg · s/ml) 0.01 0.04 0.005 0.04 0.8 0.2 0.005 0.005 
L (mmHg · s
2
/ml) 0.0005 0.0002 0.0005 0.0005 0.0005 0.0005 0.0005 0.0005 
Ω (mmHg · s/ml) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
E0 (mmHg/ ml) 0.001 0.08 0.01 1.5 0.04 0.005 0.001 0.05 
Φ (ml) 20 100 270 20 550 100 3200 20 
        
 
Left 
ventricle 
right 
ventricle left atria right atria   Pericardium 
Ω  (mmHg · s/ml) 0.0001 0.0001 0.0005 0.0005  Kpc (mmHg ) 1 
Eb (mmHg/ ml) 0.07 0.05 0.09 0.06  Vpc0 (ml) 380 
Ea (mmHg/ ml) 6 0.7 0.07 0.04  Φ (ml) 40 
      Vpe (ml) 30 
        
 
Mitral 
valve Aortic valve 
Tricuspid 
valve 
Pulmonary 
valve   
Intrathoracic 
pressure 
R (mmHg · s
2
/ml) 0.001 0.001 0.001 0.01  Pitb (mmHg) -3.7 
L (mmHg · s
2
/ml) 0.0002 0.0005 0.0002 0.0005  Pita (mmHg) -1.8 
A (cm
2
) 5 4 5 4  Tit  (s) 0.1 
        
 tr  (s) tee (s) tar (s) tac (s) vc
τ  (s) 
vr
τ  (s) aτ  (s) 
  0.855 0.3 0.9 0.695 0.4 0.02 0.05 
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Table A2 – Baroreflex control  parameters 
Afferent compartment s 0.001=affτ  
 1=affG  
Central Compartment Pdemand  = 90 mmHg 
Parasympathetic 
division 
Sp  = 0.0205 
PNAmax  = 6 Hz 
PNAmin  = 0.6 Hz 
Efferent compartment 
 
Sympathetic 
division 
Ss = -0.0138 
SNAmax = 4 Hz 
SNAmin  =1.12 Hz 
Sympathetic 
division 
k
sˆG 0 =  90 beats/min /Hz 
τ
0sˆG  = 10 beats/min /Hz 
k
sˆk 0  = 0.28 
τ
0sˆk  = 0.2 
sˆT  = 3s 
Parasympathetic 
division 
0vˆG  = 60 beats/min /Hz 
0vˆk  = 0.4 
vˆτ  = 0.1s / 0.8s 
vˆT  = 0.5 s 
Heart rate 
interaction between two 
divisions 
c = 0.017 
HR0 = 109 beats/min 
 
left heart 
lv,στ    = 1.5 s 
Te, lv   = 2 s 
Geff ,lv = 0.45 mmHg/ml/Hz 
Elv0     = 3 mmHg/ml 
Myocardial  
constriction 
right heart Erv0  = 0.1 mmHg/ml 
rv,στ   = 1.5 s 
Te, rv = 2 s 
Geff ,rv = 0.282 mmHg/ml/Hz 
Veins 
V,στ   = 10 s 
Te,V = 5 s  
Geff,V = -275 ml/Hz 
V0 = 3200 ml 
Effector  
sites 
 
 
Arterioles  
R,στ   = 1.5 s 
Te,R   = 3 s 
Geff,R = 0.2 mmHg/(ml/s)/Hz 
R0        = 0.3 mmHg/(ml/s) 
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Table A3 – Respiratory and chemoreceptor  parameters 
Variables Value  Variables Value 
 
Lung Brain 
Residual volume 1.2 L Brain blood flow conductance 5.7 (L/min)/bar 
Total lung capacity 6 L Brain oxygen consumption rate 0.05 L/min 
Functional residual capacity 2.4 L Brain respiratory quotient  0.8 
Effective moving mass of lung 0.5 kg Total brain blood capillary 
volume 
0.9 L 
Lung constant effective surface 
area 
0.125 m
2
 Cardiac output time constant  6 seconds 
Lung minimum effective surface 
area 
0.105 m
2
 Brain blood flow time constant  6 seconds 
Lung elastance when lung at un-
stretched region 
5 cm water/L Ratio between brain blood flow 
and cardiac output 
0.15 
Lung volume when lung stretched 5.5 L Inspiratory time chemical 
controller gain 
0.062 
Maximum lung elastance 10 cm water/L Expiratory time chemical 
controller gain 
0.4 
Viscous friction coefficient 500 N/(m/s) Thoracic force integral gain for 
inspiration 
335 
Polytropic index 1 Thoracic force proportional gain 
for inspiration 
6.7 
Intra-pulmonary airway resistance 0.001cm 
water/(L/s) 
Thoracic force integral gain for 
expiration 
335 
Fractional flow rate from right to 
left shunt 
0.02 Thoracic force proportional gain 
for expiration 
50 
Solubility coefficient of N2 in 
blood 
0.013  
L/(L blood atm) 
Time constant factor of demand 
lung profile 
0.15 
Solubility coefficient of He in 
blood 
0.003  
L/(L blood atm) 
Thoracic force derivative term 
gain 
10
5
 
Saturated oxygen capacity in blood  0.2 L/L blood Minimum thoracic force -700N 
Saturated carbon dioxide capacity 
in blood 
1 L/L blood Maximum thoracic force 700N 
Nose Mouth 
Equivalent diameter of nostril 22.5 mm Effective diameter of mouth  22.5 mm 
Width of linear flow region 0.0001 bar Width of linear flow region  10
-4 
bar 
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Table A3 – Respiratory and chemoreceptor  parameters (contd…) 
Variables Value Variables Value 
Trachea  
Nominal radius of airway without 
traction  
0.0001 m Number of tracheobronchial 
airway 
16400 
Addition airway radius with airway 
traction 
0.0002 m Width of linear flow region 0.0001 bar 
Trachea wall stiffness 7000 N/m Closing lung volume 0.9 L 
Length of moving tracheobronchial 
wall 
0.001 m Total lung capacity 6 L 
Minimum radius of extra-pulmonary 
airway 
0 m Nominal radius of airway without 
traction  
0.0001 m 
Maximum radius of extra-pulmonary 
airway 
0.0003686 
m 
Addition airway radius with 
airway traction 
0.0002 m 
Total volume of intra-thoracic zone 0.052 L Trachea wall stiffness 7000 N/m 
Total volume of extra-thoracic zone  0.123 L Length of moving 
tracheobronchial wall 
0.001 m 
 Minimum radius of extra-
pulmonary airway 
0 m 
Peripheral chemoreceptor Central chemoreceptor 
Peripheral chemoreceptor constant k1 -13.8 Central chemoreceptor constant k4 1 
Peripheral chemoreceptor constant k2 0.182 Central chemoreceptor constant k5 -18.118 
Peripheral  chemoreceptor constant k3 828  
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Fig. 1 Block diagram of the human cardiopulmonary system  
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Fig. 2 Block diagram of the human baroreflex and chemoreflex control system  
(Eq. refers to associated equations numbers in the text) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 3 Block diagram of heart rate control scheme (associated with Eqs (18) – (28)) 
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Fig. 4 Pressure of left ventricle, aorta and left atrium (Simulation results and experimental data taken Sugawara et al 
[33])  
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Fig. 5 Heart valve flow and venous return for left and right heart 
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Fig. 6  Alveolar Po2 and Pco2 responses to hypoxia 
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Fig. 7 Heart rate response to hypoxia with baroreceptor denervated 
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Fig. 8 Mean arterial pressure response to hypoxia with baroreceptor and chemoreceptor stimulated 
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Fig. 9 Heart rate response to hypoxia with baroreceptor and chemoreceptor stimulated 
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Fig. 10 Total peripheral resistance response to hypoxia with baroreceptor and chemoreceptor stimulated 
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Fig. 11 Normalized values of heart rate (HR), mean arterial pressure (MAP), and total peripheral resistance (TPR) 
compared with experimental data from Cooper et al [35] during hypoxia  
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Fig. 12 Model predicted heart rate (HR), mean arterial pressure (MAP), and total peripheral resistance (TPR) 
compared with experimental data from Cooper et al [35]  with denervated central chemoreceptor during hypercapnia 
  33 
HR MAP TPR
-15
-10
-5
0
5
10
15
20
25
%
 c
h
a
n
g
e
 o
f 
n
o
rm
a
l 
c
o
n
d
it
io
n
Cooper et al.
modelled
 
Fig. 13 Model predicted heart rate (HR), mean arterial pressure (MAP), and total peripheral resistance (TPR) 
compared with experimental data from Cooper et al [35] after innervated central chemoreceptor during hypercapnia 
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Fig. 14 Primary recording of cardiovascular variables from 1 typical experiment.  
MAP: Mean Arterial Pressure; HR: Heart Rate (beats/min); SV: Stroke Volume; CO: Cardiac Output;  
TPC: Total Peripheral Conductance (calculated by dividing CO by MAP, unit: l·min
-1
·mmHg
-1
) (Toska and Eriksen 
[36]) 
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Fig. 15 Cardiovascular response predicted by the model.  
MAP: Mean Arterial Pressure; HR: Heart Rate (beats/min); SV: Stroke Volume; CO: Cardiac Output;  
TPC: Total Peripheral Conductance  
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